Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Clinical trial NCT01134341 · COMPLETED

Trial details

NCT number: NCT01134341
Sponsor: Acrotech Biopharma Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous T-cell Lymphoma Mycosis Fungoides Sezary Syndrome Primary Cutaneous Anaplastic Large Cell Lymphoma

Start date: 2010-03-01
Primary completion: 2015-08-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.